Abstract

Clinical trials of biodynamic digital holography in human esophageal cancer and canine B-cell lymphoma, performed within 24 hours of biopsy acquisition, have an accuracy of 90% identifying patients resistant to their prescribed chemotherapy. Translation of this biomedical optical technology to clinical laboratory services has the potential to transform personalized cancer care.

© 2018 The Author(s)

PDF Article
More Like This
Intracellular Doppler Spectroscopy and Deep Learning in Clinical Trials to Personalize Cancer Chemotherapy

David Nolte, Ran An, and John Turek
EW1C.4 European Conference on Biomedical Optics (ECBO) 2021

Doppler Imaging of Intracellular Dynamics in Clinical Cancer Chemotherapy

David D. Nolte, John J. Turek, Daniela E. Matei MD, and Shadia Jalal MD
11073_18 European Conference on Biomedical Optics (ECBO) 2019

Biodynamic 4D Imaging of Living Cancer Biopsies for Personalized Selection of Chemotherapy

David D. Nolte, Zhe Li, Honggu Choi, John Turek, and Shadia Jalal
CTu4B.7 Clinical and Translational Biophotonics (Translational) 2018

References

You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access Optica Member Subscription